Correlation Between Genocea Biosciences and Ascletis Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genocea Biosciences and Ascletis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genocea Biosciences and Ascletis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genocea Biosciences and Ascletis Pharma, you can compare the effects of market volatilities on Genocea Biosciences and Ascletis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genocea Biosciences with a short position of Ascletis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genocea Biosciences and Ascletis Pharma.

Diversification Opportunities for Genocea Biosciences and Ascletis Pharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Genocea and Ascletis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Genocea Biosciences and Ascletis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascletis Pharma and Genocea Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genocea Biosciences are associated (or correlated) with Ascletis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascletis Pharma has no effect on the direction of Genocea Biosciences i.e., Genocea Biosciences and Ascletis Pharma go up and down completely randomly.

Pair Corralation between Genocea Biosciences and Ascletis Pharma

If you would invest  21.00  in Ascletis Pharma on October 7, 2024 and sell it today you would earn a total of  3.00  from holding Ascletis Pharma or generate 14.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Genocea Biosciences  vs.  Ascletis Pharma

 Performance 
       Timeline  
Genocea Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genocea Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Genocea Biosciences is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Ascletis Pharma 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ascletis Pharma are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating essential indicators, Ascletis Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Genocea Biosciences and Ascletis Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genocea Biosciences and Ascletis Pharma

The main advantage of trading using opposite Genocea Biosciences and Ascletis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genocea Biosciences position performs unexpectedly, Ascletis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascletis Pharma will offset losses from the drop in Ascletis Pharma's long position.
The idea behind Genocea Biosciences and Ascletis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities